Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Radium-223 in prostate cancer.

Literature DB >> 24152265

Radium-223 in prostate cancer.

Chris Parker, Oliver Sartor.

Abstract

Entities: Chemical

Mesh：

Substances：
Radium

Year: 2013 PMID： 24152265 DOI： 10.1056/NEJMc1310231

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

Review 1. From palliative therapy to prolongation of survival: (223)RaCl2 in the treatment of bone metastases.

Authors: Knut Liepe; Ajit Shinto
Journal: Ther Adv Med Oncol Date: 2016-04-25 Impact factor: 8.168

2. Orteronel for the treatment of prostate cancer.

Authors: Kathryn Van Hook; Ted Huang; Joshi J Alumkal
Journal: Future Oncol Date: 2014-04 Impact factor: 3.404

3. A phase II study of GW786034 (pazopanib) with or without bicalutamide in patients with castration-resistant prostate cancer.

Authors: Srikala S Sridhar; Anthony M Joshua; Richard Gregg; Christopher M Booth; Nevin Murray; Jovana Golubovic; Lisa Wang; Pamela Harris; Kim N Chi
Journal: Clin Genitourin Cancer Date: 2014-06-08 Impact factor: 2.872

4. Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis.

Authors: Francesco Massari; Chiara Ciccarese; Anna Caliò; Enrico Munari; Luca Cima; Antonio Benito Porcaro; Giovanni Novella; Walter Artibani; Teodoro Sava; Albino Eccher; Claudio Ghimenton; Francesco Bertoldo; Aldo Scarpa; Nicola Sperandio; Camillo Porta; Vincenzo Bronte; Marco Chilosi; Giuseppe Bogina; Giuseppe Zamboni; Giampaolo Tortora; Hemamali Samaratunga; Guido Martignoni; Matteo Brunelli
Journal: Target Oncol Date: 2016-06 Impact factor: 4.493

Review 5. Prostate cancer.

Authors: Richard J Rebello; Christoph Oing; Karen E Knudsen; Stacy Loeb; David C Johnson; Robert E Reiter; Silke Gillessen; Theodorus Van der Kwast; Robert G Bristow
Journal: Nat Rev Dis Primers Date: 2021-02-04 Impact factor: 52.329

6. Consensus on the Treatment and Follow-Up for Metastatic Castration-Resistant Prostate Cancer: A Report From the First Global Prostate Cancer Consensus Conference for Developing Countries (PCCCDC).

Authors: Fernando Cotait Maluf; Felipe Moraes Toledo Pereira; Adriano Gonçalves Silva; Aldo Lourenço Abbade Dettino; Ana Paula Garcia Cardoso; André Seeke Sasse; Andrey Soares; Ariel Galapo Kann; Daniel Herchenhorn; Denis Leonardo Fontes Jardim; Diego Emilio Lopera Cortés; Fábio Roberto Kater; Igor A Protzner Morbeck; João Francisco Navarro Reolon; José Augusto Rinck; Juan Jose Zarbá; Juan Pablo Sade; Karine Martins da Trindade; Leonardo Atem G A Costa; Lucas V Dos Santos; Manuel Caitano Maia; Mariana Bruno Siqueira; Silke Gillessen
Journal: JCO Glob Oncol Date: 2021-04

Radium-223 in prostate cancer.

Review 1. From palliative therapy to prolongation of survival: (223)RaCl2 in the treatment of bone metastases.

2. Orteronel for the treatment of prostate cancer.

3. A phase II study of GW786034 (pazopanib) with or without bicalutamide in patients with castration-resistant prostate cancer.

4. Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis.

Review 5. Prostate cancer.

6. Consensus on the Treatment and Follow-Up for Metastatic Castration-Resistant Prostate Cancer: A Report From the First Global Prostate Cancer Consensus Conference for Developing Countries (PCCCDC).

7. Real-time scintigraphic assessment of intravenous radium-223 administration for quality control.

Review 8. Radioligand therapy of metastatic castration-resistant prostate cancer: current approaches.

9. Present and Future Prospects of Radiation Therapy Using α-Emitting Nuclides.

10. Radioligand therapy of metastatic prostate cancer using ¹⁷⁷Lu-PSMA-617 after radiation exposure to ²²³Ra-dichloride.